AM Best Assigns Exceptional Rating to Ryan Specialty
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 43 minutes ago
0mins
Source: Newsfilter
- Rating Assessment: AM Best has assigned a PA-1 (Exceptional) rating to Ryan Specialty (Singapore) Pte. Limited, reflecting its exceptional underwriting capabilities and governance structure, with a stable outlook indicating strong competitive positioning in the insurance market.
- Underwriting Performance: RSUM operates over 300 specialized insurance products in the specialty insurance market, effectively serving complex and underserved market segments, bolstered by centralized underwriting and catastrophe modeling teams, which further solidifies its market position.
- Financial Condition: In 2025, RSUM recorded strong growth in gross premiums and revenue, supported by robust organic growth and strategic acquisitions, ensuring sustained profitability and capital access, enhancing its competitive edge in the market.
- Strategic Investment: Through a strategic joint venture with Nationwide Mutual Insurance Company, Ryan Specialty has strengthened its risk participation in underwriting results, enhancing long-term sustainability while continuously expanding its market share through disciplined acquisition strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RYAN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RYAN
Wall Street analysts forecast RYAN stock price to rise
16 Analyst Rating
10 Buy
5 Hold
1 Sell
Moderate Buy
Current: 33.110
Low
56.00
Averages
64.57
High
82.00
Current: 33.110
Low
56.00
Averages
64.57
High
82.00
About RYAN
Ryan Specialty Holdings, Inc. is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers. For retail insurance brokers, it assists in the placement of complex or otherwise hard-to-place risks. For insurance carriers, it works with retail and wholesale insurance brokers to source, onboard, underwrite, and service these same risks. It Wholesale Brokerage Specialty operates under the brand RT Specialty along with others, such as RT ProExec and CERT. Its Binding Authority Specialty operates under the RT Specialty and RT Binding Authority brands. Its Underwriting Management Specialty operates under multiple brands, which are collectively referred to as Ryan Specialty Underwriting Managers. It also specializes in builder's risk insurance.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AM Best Assigns Exceptional Rating to Ryan Specialty
- Rating Assessment: AM Best has assigned a PA-1 (Exceptional) rating to Ryan Specialty (Singapore) Pte. Limited, reflecting its exceptional underwriting capabilities and governance structure, with a stable outlook indicating strong competitive positioning in the insurance market.
- Underwriting Performance: RSUM operates over 300 specialized insurance products in the specialty insurance market, effectively serving complex and underserved market segments, bolstered by centralized underwriting and catastrophe modeling teams, which further solidifies its market position.
- Financial Condition: In 2025, RSUM recorded strong growth in gross premiums and revenue, supported by robust organic growth and strategic acquisitions, ensuring sustained profitability and capital access, enhancing its competitive edge in the market.
- Strategic Investment: Through a strategic joint venture with Nationwide Mutual Insurance Company, Ryan Specialty has strengthened its risk participation in underwriting results, enhancing long-term sustainability while continuously expanding its market share through disciplined acquisition strategies.
See More
Guardian Point Capital Increases Stake in Ryan Specialty Holdings
- Stake Increase: Guardian Point Capital added 75,000 shares of Ryan Specialty Holdings in Q1, with an estimated trade value of $3.20 million, raising its total holdings to 575,000 shares valued at $19.40 million, indicating sustained confidence in the company.
- Market Value Fluctuation: Despite the increase in shares, the quarter-end position value fell by $6.41 million, reflecting the impact of market price movements and trading activities, suggesting investors should monitor market dynamics closely.
- Financial Performance: Ryan Specialty achieved a 15.2% revenue growth in Q1, reaching $795.2 million, while adjusted earnings per share rose by 20.5% to $0.47, demonstrating strong growth potential in a competitive insurance market.
- Market Confidence: Management remains confident about gaining market share despite tougher insurance conditions, emphasizing ongoing investments in technology, AI, and data capabilities to strengthen competitive positioning.
See More
Guardian Point Capital Increases Stake in Ryan Specialty Holdings
- Stake Increase: Guardian Point Capital increased its stake in Ryan Specialty Holdings by 75,000 shares in Q1 2026, representing an estimated $3.20 million trade, indicating confidence in the company's future.
- Total Holdings Change: Following this purchase, Guardian Point's total holdings rose to 575,000 shares, although the quarter-end value of the stake decreased by $6.41 million due to stock price fluctuations, highlighting the impact of market volatility on investments.
- Financial Performance: Ryan Specialty reported a 15.2% year-over-year revenue increase to $795.2 million in Q1, with adjusted earnings per share rising 20.5% to $0.47, demonstrating resilience in a challenging insurance market.
- Market Outlook: Despite a 55% decline in Ryan Specialty's stock price over the past year, management remains optimistic about gaining market share, emphasizing ongoing investments in technology and data capabilities to strengthen the company's competitive position.
See More
Guardian Point Capital Increases Stake in Ryan Specialty Holdings
- Stake Increase Details: According to an SEC filing dated May 15, 2026, Guardian Point Capital increased its stake in Ryan Specialty Holdings by 75,000 shares in Q1, representing an estimated $3.20 million trade, bringing its total holdings to 575,000 shares, indicating ongoing confidence in the company.
- Stock Price Impact: Despite the increase in shares, the quarter-end value of Ryan Specialty's stake decreased by $6.41 million due to stock price fluctuations, reflecting a 55% decline in share price over the past year, underperforming the S&P 500, which rose 28% during the same period.
- Financial Performance Highlights: Ryan Specialty reported a 15.2% year-over-year revenue increase to $795.2 million in Q1, with adjusted earnings per share rising 20.5% to $0.47, demonstrating strong growth potential even in a challenging insurance market.
- Market Outlook: Management expressed optimism about future market conditions, emphasizing ongoing investments in technology and data capabilities to strengthen competitiveness, and Guardian Point's purchase is seen as a positive response to recent stock weakness, indicating confidence in the company's long-term prospects.
See More
Ryan Specialty Increases Share Repurchase Authorization by $300M
- Authorization Increase: Ryan Specialty Holdings' board approved a $300 million increase to its existing share repurchase authorization, reflecting the company's confidence in its stock value and aiming to enhance shareholder returns.
- Repurchase Progress: As of May 22, 2026, the company repurchased $260 million of Class A common stock in Q2, exhausting its previous $300 million authorization, indicating an active use of the repurchase plan to support its stock price.
- Remaining Authorization: Following the increase, there remains $300 million of repurchase authorization available under the current program, providing ample funding for future stock buybacks and likely boosting market confidence in the company.
- Market Outlook: Despite property rate pressures, Ryan Specialty forecasts mid-single-digit organic growth for 2026, with an expected adjusted EBITDAC margin decline of 100-150 basis points, demonstrating the company's potential for growth even amid challenges.
See More
Pomerantz LLP Investigates Securities Fraud Claims Against Ryan Specialty Holdings
- Declining Financial Performance: Ryan Specialty Holdings reported a fourth-quarter organic revenue growth of 6.6%, down from 11.0% in the prior year, indicating pressure in market competition that could undermine investor confidence moving forward.
- EBITDAC Margin Decline: The company's adjusted EBITDAC margin fell to 29.6% from 32.6% year-over-year, reflecting rising costs and changes in market conditions that negatively impact profitability, potentially raising concerns among investors about future performance.
- Significant Stock Price Drop: On February 13, 2026, Ryan's stock price fell by $5.67, or 12.78%, closing at $38.71 per share, indicating a pessimistic outlook from the market regarding the company's financial prospects, which may trigger further legal actions from investors.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Ryan and its executives engaged in securities fraud or other unlawful business practices, highlighting potential legal risks that could further affect the company's market reputation and shareholder trust.
See More
AM Best Assigns Exceptional Rating to Ryan Specialty
- Rating Assessment: AM Best has assigned a PA-1 (Exceptional) rating to Ryan Specialty (Singapore) Pte. Limited, reflecting its exceptional underwriting capabilities and governance structure, with a stable outlook indicating strong competitive positioning in the insurance market.
- Underwriting Performance: RSUM operates over 300 specialized insurance products in the specialty insurance market, effectively serving complex and underserved market segments, bolstered by centralized underwriting and catastrophe modeling teams, which further solidifies its market position.
- Financial Condition: In 2025, RSUM recorded strong growth in gross premiums and revenue, supported by robust organic growth and strategic acquisitions, ensuring sustained profitability and capital access, enhancing its competitive edge in the market.
- Strategic Investment: Through a strategic joint venture with Nationwide Mutual Insurance Company, Ryan Specialty has strengthened its risk participation in underwriting results, enhancing long-term sustainability while continuously expanding its market share through disciplined acquisition strategies.
See More
Guardian Point Capital Increases Stake in Ryan Specialty Holdings
- Stake Increase: Guardian Point Capital added 75,000 shares of Ryan Specialty Holdings in Q1, with an estimated trade value of $3.20 million, raising its total holdings to 575,000 shares valued at $19.40 million, indicating sustained confidence in the company.
- Market Value Fluctuation: Despite the increase in shares, the quarter-end position value fell by $6.41 million, reflecting the impact of market price movements and trading activities, suggesting investors should monitor market dynamics closely.
- Financial Performance: Ryan Specialty achieved a 15.2% revenue growth in Q1, reaching $795.2 million, while adjusted earnings per share rose by 20.5% to $0.47, demonstrating strong growth potential in a competitive insurance market.
- Market Confidence: Management remains confident about gaining market share despite tougher insurance conditions, emphasizing ongoing investments in technology, AI, and data capabilities to strengthen competitive positioning.
See More
Guardian Point Capital Increases Stake in Ryan Specialty Holdings
- Stake Increase: Guardian Point Capital increased its stake in Ryan Specialty Holdings by 75,000 shares in Q1 2026, representing an estimated $3.20 million trade, indicating confidence in the company's future.
- Total Holdings Change: Following this purchase, Guardian Point's total holdings rose to 575,000 shares, although the quarter-end value of the stake decreased by $6.41 million due to stock price fluctuations, highlighting the impact of market volatility on investments.
- Financial Performance: Ryan Specialty reported a 15.2% year-over-year revenue increase to $795.2 million in Q1, with adjusted earnings per share rising 20.5% to $0.47, demonstrating resilience in a challenging insurance market.
- Market Outlook: Despite a 55% decline in Ryan Specialty's stock price over the past year, management remains optimistic about gaining market share, emphasizing ongoing investments in technology and data capabilities to strengthen the company's competitive position.
See More
Guardian Point Capital Increases Stake in Ryan Specialty Holdings
- Stake Increase Details: According to an SEC filing dated May 15, 2026, Guardian Point Capital increased its stake in Ryan Specialty Holdings by 75,000 shares in Q1, representing an estimated $3.20 million trade, bringing its total holdings to 575,000 shares, indicating ongoing confidence in the company.
- Stock Price Impact: Despite the increase in shares, the quarter-end value of Ryan Specialty's stake decreased by $6.41 million due to stock price fluctuations, reflecting a 55% decline in share price over the past year, underperforming the S&P 500, which rose 28% during the same period.
- Financial Performance Highlights: Ryan Specialty reported a 15.2% year-over-year revenue increase to $795.2 million in Q1, with adjusted earnings per share rising 20.5% to $0.47, demonstrating strong growth potential even in a challenging insurance market.
- Market Outlook: Management expressed optimism about future market conditions, emphasizing ongoing investments in technology and data capabilities to strengthen competitiveness, and Guardian Point's purchase is seen as a positive response to recent stock weakness, indicating confidence in the company's long-term prospects.
See More
Ryan Specialty Increases Share Repurchase Authorization by $300M
- Authorization Increase: Ryan Specialty Holdings' board approved a $300 million increase to its existing share repurchase authorization, reflecting the company's confidence in its stock value and aiming to enhance shareholder returns.
- Repurchase Progress: As of May 22, 2026, the company repurchased $260 million of Class A common stock in Q2, exhausting its previous $300 million authorization, indicating an active use of the repurchase plan to support its stock price.
- Remaining Authorization: Following the increase, there remains $300 million of repurchase authorization available under the current program, providing ample funding for future stock buybacks and likely boosting market confidence in the company.
- Market Outlook: Despite property rate pressures, Ryan Specialty forecasts mid-single-digit organic growth for 2026, with an expected adjusted EBITDAC margin decline of 100-150 basis points, demonstrating the company's potential for growth even amid challenges.
See More
Pomerantz LLP Investigates Securities Fraud Claims Against Ryan Specialty Holdings
- Declining Financial Performance: Ryan Specialty Holdings reported a fourth-quarter organic revenue growth of 6.6%, down from 11.0% in the prior year, indicating pressure in market competition that could undermine investor confidence moving forward.
- EBITDAC Margin Decline: The company's adjusted EBITDAC margin fell to 29.6% from 32.6% year-over-year, reflecting rising costs and changes in market conditions that negatively impact profitability, potentially raising concerns among investors about future performance.
- Significant Stock Price Drop: On February 13, 2026, Ryan's stock price fell by $5.67, or 12.78%, closing at $38.71 per share, indicating a pessimistic outlook from the market regarding the company's financial prospects, which may trigger further legal actions from investors.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Ryan and its executives engaged in securities fraud or other unlawful business practices, highlighting potential legal risks that could further affect the company's market reputation and shareholder trust.
See More
